09-04-2014 - 11-04-2014 Tokyo
Leading event organiser UBM Live announces that CPhI Japan is returning for its 12th year to Tokyo.
Leading event organiser UBM Live announces that CPhI Japan is returning for its 12th year to Tokyo. The event will once again be co-locating to provide an all-round experience, creating a pivotal meeting-point for all sectors of the pharmaceutical industry. The full line-up of events includes ICSE Japan, a dedicated outsourcing event designed to connect the pharmaceutical community with contract service providers; P-MEC Japan, delivering innovative pharmaceutical technology, machinery and equipment to a forum of decision makers; BioPh Japan, showcasing the biopharma sector, and a further two events- Pharmatec, providing a pharmaceutical packaging focus and MEDTEC Japan, specialising in medical devices.
Japan is the second largest pharmaceutical market in the world and has been forecast to grow even further at a CAGR of 2.6% until 2016, reaching a total value of $127.4 billion. The pharma community in the country continues to innovate, particularly in regards to medical devices, with growth facilitated through a reduction in stringent regulatory guidelines. These factors have enabled the Japanese pharma market to open up to foreign investment, meaning that there has never been a better time to attend CPhI Japan and its co-located events.
Last year the event hosted over 14,000 attendees and more than 500 exhibitors. A major highlight for this year’s event is again the 150 free seminars covering current industry trends and providing invaluable insights into the dynamic Japanese pharmaceutical industry. Contributors to the seminars include a wide spectrum of esteemed representatives including the Ministry of Health, Labour & Welfare Japan and the European Federation of Pharmaceutical Industries & Associations Japan (EFPIA Japan).
Exhibitors are invited to take part in this year’s presentation series, to educate the industry about their latest products, services, innovations and company news during a 30-minute presentation that will be attended by visitors, press and fellow exhibitors.
Chris Kilbee, group director, CPhI & Pharma, said: “The Japanese pharmaceutical market is second only to the US, representing one of the strongest areas for those looking to invest. More recently, Japan has seen more amicable regulatory guidelines, which has generated an attractive platform for international investment and our event provides the ultimate setting for both suppliers and buyers to benefit from this dynamic market.”